rs371151471
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_018100.4(EFHC1):c.1114C>T(p.Arg372Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00049 in 1,613,706 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_018100.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EFHC1 | NM_018100.4 | c.1114C>T | p.Arg372Trp | missense_variant | 6/11 | ENST00000371068.11 | NP_060570.2 | |
EFHC1 | NM_001172420.2 | c.1057C>T | p.Arg353Trp | missense_variant | 7/12 | NP_001165891.1 | ||
EFHC1 | NR_033327.2 | n.2440C>T | non_coding_transcript_exon_variant | 5/10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EFHC1 | ENST00000371068.11 | c.1114C>T | p.Arg372Trp | missense_variant | 6/11 | 1 | NM_018100.4 | ENSP00000360107.4 |
Frequencies
GnomAD3 genomes AF: 0.000276 AC: 42AN: 152074Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.00121 AC: 304AN: 251092Hom.: 2 AF XY: 0.00166 AC XY: 225AN XY: 135764
GnomAD4 exome AF: 0.000512 AC: 749AN: 1461514Hom.: 5 Cov.: 31 AF XY: 0.000754 AC XY: 548AN XY: 727078
GnomAD4 genome AF: 0.000269 AC: 41AN: 152192Hom.: 1 Cov.: 32 AF XY: 0.000484 AC XY: 36AN XY: 74412
ClinVar
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Jan 05, 2016 | A variant of uncertain significance has been identified in the EFHC1 gene. The R372W variant has been reported previously in association with juvenile myoclonic epilepsy; however, additional information was not provided (Praveen K et al., 2013). It was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, but the 1000 Genomes Project reports R372W was observed in 10/978 (1%) alleles from individuals of South Asian background, indicating it may be a rare (benign) variant in this population. This substitution occurs at a position that is not conserved. However, the R372W variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. In silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. Therefore, based on the currently available information, it is unclear whether this variant is a pathogenic variant or a rare benign variant. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Nov 20, 2023 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Aug 14, 2014 | - - |
Myoclonic epilepsy, juvenile, susceptibility to, 1;C2750892:Epilepsy, juvenile absence, susceptibility to, 1 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago | Mar 30, 2021 | EFHC1 NM_018100.3 exon 6 p.Arg372Trp (c.1114C>T): This variant has been reported in the literature in several individuals with Juvenile Myoclonic Epilepsy (JME) (Raju 2017 PMID:28370826). However, this variant is present in 0.9% (304/30778) of South Asian alleles, including 2 homozygotes, in the Genome Aggregation Database (http://gnomad.broadinstitute.org/rs371151471). This variant is present in ClinVar (Variation ID:205403). Evolutionary conservation and computational predictive tools for this variant are unclear. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. - |
Absence seizure;C0270853:Juvenile myoclonic epilepsy Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago | Jul 09, 2018 | EFHC1 NM_018100.3 exon 6 p.Arg372Trp (c.1114C>T): This variant has been reported in the literature in several individuals with Juvenile Myoclonic Epilepsy (JME) (Raju 2017 PMID:28370826). However, this variant is present in 0.9% (304/30778) of South Asian alleles, including 2 homozygotes, in the Genome Aggregation Database (http://gnomad.broadinstitute.org/rs371151471). This variant is present in ClinVar (Variation ID:205403). Evolutionary conservation and computational predictive tools for this variant are unclear. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. - |
Absence seizure;C1850778:Myoclonic epilepsy, juvenile, susceptibility to, 1 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 10, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at